Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: Clinical experience in 21 patients
- 1 September 1987
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 114 (3), 589-595
- https://doi.org/10.1016/0002-8703(87)90757-5
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Long-term therapy with a new cardiotonic agent, WIN 47203: Drug-dependent improvement in cardiac performance and progression of the underlying diseaseJournal of the American College of Cardiology, 1983
- The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.Circulation, 1983
- Congestive heart failure: A propitious time for intensified researchThe American Journal of Cardiology, 1983
- Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failureThe American Journal of Cardiology, 1983
- Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.Circulation, 1982
- Long-term benefit of dobutamine in patients with congestive cardiomyopathyAmerican Heart Journal, 1980
- Dobutamine: A New Synthetic Cardioactive Sympathetic AmineNew England Journal of Medicine, 1979
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978
- The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.Circulation, 1977